IR Searcher

年度	タイプ	日付	売上高	営業利益	経常利益	純利益
2023-03	新規	2022-05-11	76400	15000	15500	12000
	修正	2023-02-03	73500(↓)	7500(↓)	8100(↓)	6100(↓)
2024-03	新規	2023-05-10	73100	7600	8000	6700
来期	新規	2024-05-14	75100	7400	7800	5600

通期四半期別

　※来期予想のグラフはQ1と表記されているがQ4である。

通期四半期別

決算期	四半期	売上高	営業利益	経常利益	純利益	1株当たり純利益	営業利益率	経常利益率	売上高/前年比	営業利益/前年比	経常利益/前年比	純利益/前年比
予想		75100	7400	7800	5600		9.85%	10.39%	4.2%	-22.2%	-21.6%	-30.2%
2024-03	4	72044	9513	9951	8025	212.67	13.2%	13.81%	-1.3%	18.9%	14%	47.5%
	3	54685	8873	9304	6675	177.1	16.23%	17.01%	-1.6%	-28.4%	-28.3%	-27%
	2	36171	5512	5722	4068	108.18	15.24%	15.82%	-1.8%	-32.8%	-33.1%	-31.8%
	1	18150	3293	3488	2510	66.99	18.14%	19.22%	-0.3%	-18.8%	-19.5%	-13.7%
2023-03	4	72984	7998	8727	5440	144.8	10.96%	11.96%	-4%	-53.1%	-50.3%	-43%
	3	55573	12394	12976	9149	243.31	22.3%	23.35%	-3.7%	-10.8%	-9.4%	-10.7%
	2	36819	8209	8555	5964	158.34	22.3%	23.24%	-2%	-9.2%	-7.9%	-11.3%
	1	18197	4056	4332	2907	76.91	22.29%	23.81%	-1.4%	-8.3%	-7%	-13.5%
2022-03	4	76034	17064	17542	9549	251.43	22.44%	23.07%	1.4%	-4.1%	-3.7%	-28.8%
	3	57708	13889	14322	10246	269.41	24.07%	24.82%	1.1%	-7.1%	-6.7%	-6.3%
	2	37588	9036	9290	6721	176.24	24.04%	24.72%	2.2%	-7.6%	-7.2%	-7%
	1	18453	4421	4660	3362	87.78	23.96%	25.25%	2.1%	-12.1%	-11.2%	-12%
2021-03	4	74979	17788	18222	13405	347.37	23.72%	24.3%	-16%	-32.9%	-32.4%	-30.8%
	3	57082	14949	15347	10934	282.69	26.19%	26.89%	-18.7%	-33.4%	-32.8%	-29.7%
	2	36789	9782	10010	7226	186.15	26.59%	27.21%	-18.6%	-28.8%	-28.1%	-24.3%
	1	18070	5031	5249	3820	98.18	27.84%	29.05%	-19.1%	-25%	-23.9%	-20.8%
2020-03	4	89232	26512	26946	19370	494.89	29.71%	30.2%	-5.2%	7.8%	7.9%	9%
	3	70178	22432	22829	15554	396.67	31.96%	32.53%	-3.3%	12.7%	12.7%	9.2%
	2	45170	13744	13929	9547	242.56	30.43%	30.84%	-4.9%	11.2%	11.1%	8%
	1	22335	6705	6898	4826	121.65	30.02%	30.88%	-7.5%	18.7%	18.6%	19.6%
2019-03	4	94165	24592	24972	17775	445.78	26.12%	26.52%	-4.3%	-10.6%	-10.3%	-6.7%
	3	72584	19903	20254	14247	356.84	27.42%	27.9%	-5.6%	-16%	-15.8%	-15.5%
	2	47521	12356	12536	8840	220.84	26%	26.38%	-4.7%	-19.4%	-19.2%	-18.7%

決算期	四半期	売上高	営業利益	経常利益	純利益	1株当たり純利益	営業利益率	経常利益率	売上高/前年比	営業利益/前年比	経常利益/前年比	純利益/前年比
予想	残	3056	-2113	-2151	-2425	―	―	―	―	―	―
2024-03	4	17359	640	647	1350	35.57	3.69%	3.73%	-0.3%	―	―	―
	3	18514	3361	3582	2607	68.92	18.15%	19.35%	-1.28%	-19.69%	-18.98%	-18.15%
	2	18021	2219	2234	1558	41.19	12.31%	12.4%	-3.23%	-46.57%	-47.1%	-49.04%
	1	18150	3293	3488	2510	66.99	18.14%	19.22%	-0.3%	-18.8%	-19.5%	-13.7%
2023-03	4	17411	-4396	-4249	-3709	-98.51	-25.25%	-24.4%	-4.99%	―	―	―
	3	18754	4185	4421	3185	84.97	22.32%	23.57%	-6.79%	-13.76%	-12.14%	-9.65%
	2	18622	4153	4223	3057	81.43	22.3%	22.68%	-2.68%	-10.01%	-8.79%	-8.99%
	1	18197	4056	4332	2907	76.91	22.29%	23.81%	-1.4%	-8.3%	-7%	-13.5%
2022-03	4	18326	3175	3220	-697	-17.98	17.33%	17.57%	2.4%	11.84%	12%	-128.21%
	3	20120	4853	5032	3525	93.17	24.12%	25.01%	-0.85%	-6.08%	-5.71%	-4.94%
	2	19135	4615	4630	3359	88.46	24.12%	24.2%	2.22%	-2.86%	-2.75%	-1.38%
	1	18453	4421	4660	3362	87.78	23.96%	25.25%	2.1%	-12.1%	-11.2%	-12%
2021-03	4	17897	2839	2875	2471	64.68	15.86%	16.06%	-6.07%	-30.42%	-30.17%	-35.25%
	3	20293	5167	5337	3708	96.54	25.46%	26.3%	-18.85%	-40.53%	-40.03%	-38.27%
	2	18719	4751	4761	3406	87.97	25.38%	25.43%	-18.02%	-32.5%	-32.29%	-27.85%
	1	18070	5031	5249	3820	98.18	27.84%	29.05%	-19.1%	-25%	-23.9%	-20.8%
2020-03	4	19054	4080	4117	3816	98.22	21.41%	21.61%	-11.71%	-12.99%	-12.74%	8.16%
	3	25008	8688	8900	6007	154.11	34.74%	35.59%	-0.22%	15.12%	15.31%	11.1%
	2	22835	7039	7031	4721	120.91	30.83%	30.79%	-2.36%	4.92%	4.64%	-1.75%
	1	22335	6705	6898	4826	121.65	30.02%	30.88%	-7.5%	18.7%	18.6%	19.6%
2019-03	4	21581	4689	4718	3528	88.94	21.73%	21.86%	0.19%	23.72%	24.42%	61.54%
	3	25063	7547	7718	5407	136	30.11%	30.79%	-7.28%	-9.84%	-9.68%	-9.75%
	2	23386	6709	6719	4805	―	28.69%	28.73%	-6.05%	-12.71%	-12.79%	-11.1%

4521 科研製薬 企業サイト Yahooファイナンス 日経新聞 株探 四季報

4521 科研製薬　企業サイト　　　Yahooファイナンス　日経新聞　株探　四季報